Search Ontology:
ChEBI
5-((3S)-3-[(4R)-4-acetylamino-4-carboxybutyrylamino]-3-{(1R)-1-[(1R)-1-carboxyethylcarbamoyl]ethylcarbamoyl}propyl)-2-(carboxyphenylacetylaminomethyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
- Term ID
- CHEBI:41424
- Synonyms
-
- 5-{3-(S)-(4-(R)-ACETYLAMINO-4-CARBOXY-BUTYRYLAMINO)-3-[1-(R)-(1-(R)-CARBOXY-ETHYLCARBAMOYL)-ETHYLCARBAMOYL]-PROPYL}-2-(CARBOXY-PHENYLACETYLAMINO-METHYL)-3,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID
- Definition
- References
-
- pdb-ccd:CEH
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from 5-((3S)-3-[(4R)-4-acetylamino-4-carboxybutyrylamino]-3-{(1R)-1-[(1R)-1-carboxyethylcarbamoyl]ethylcarbamoyl}propyl)-2-(carboxyphenylacetylaminomethyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
Phenotype where environments contain 5-((3S)-3-[(4R)-4-acetylamino-4-carboxybutyrylamino]-3-{(1R)-1-[(1R)-1-carboxyethylcarbamoyl]ethylcarbamoyl}propyl)-2-(carboxyphenylacetylaminomethyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
Phenotype modified by environments containing 5-((3S)-3-[(4R)-4-acetylamino-4-carboxybutyrylamino]-3-{(1R)-1-[(1R)-1-carboxyethylcarbamoyl]ethylcarbamoyl}propyl)-2-(carboxyphenylacetylaminomethyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
Phenotype affecting 5-((3S)-3-[(4R)-4-acetylamino-4-carboxybutyrylamino]-3-{(1R)-1-[(1R)-1-carboxyethylcarbamoyl]ethylcarbamoyl}propyl)-2-(carboxyphenylacetylaminomethyl)-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
Human Disease Model